Rob Volansky

FORT LAUDERDALE, Fla. — Adding certain herbs and improved nutrition to Western medicine can have myriad benefits for patients with rheumatic and

The emergence of biologic therapies ushered in an era of unprecedented positive outcomes for patients with rheumatic and autoimmune diseases

FORT LAUDERDALE, Fla. — Social determinants of health contribute to significant disparities in rheumatology care, according to a presenter at the Rheumatology Nurses Society annual conference.

Novel therapies may allow more patients with lupus to reach remission or low disease activity, according to a presenter at the AWIR annual conference.

A deep analysis of synovial tissue from patients with rheumatoid arthritis revealed fibrin-rich niches containing SPP1hi macrophages and remodeling fibroblasts, which may provide future therapeutic targets.In a study published in Science Translational Medicine, Ian Mantel, PhD, a postdoctoral fellow at Hospital for Special Surgery and Weill Cornell Medicine, and colleagues noted that the

Rheumatologists should approach the use of AI platforms with enthusiasm and caution in equal measure, according to a presenter at the AWIR annual conference.

New B-cell targeting agents could potentially usher in a “new era” of Sjögren's disease treatment, with the first FDA approval expected within the next year, according to a presenter at the AWIR annual conference.

Communication and collaboration between juvenile- and adult-care rheumatologists will be essential in the face of workforce shortages across pediatric rheumatology , according to a presenter.

Patient populations with inflammatory musculoskeletal disorders are aging rapidly, and the research exploring aging processes is not always keeping pace.

Women in positions of leadership across medicine should advocate for the resources to improve their institutions or departments, according to a presenter at the AWIR annual conference.